TR200102501T2 - Antiviral nükleozid analoglar. - Google Patents
Antiviral nükleozid analoglar.Info
- Publication number
- TR200102501T2 TR200102501T2 TR2001/02501T TR200102501T TR200102501T2 TR 200102501 T2 TR200102501 T2 TR 200102501T2 TR 2001/02501 T TR2001/02501 T TR 2001/02501T TR 200102501 T TR200102501 T TR 200102501T TR 200102501 T2 TR200102501 T2 TR 200102501T2
- Authority
- TR
- Turkey
- Prior art keywords
- nucleoside analogs
- antiviral nucleoside
- antiviral
- analogs
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Söz konusu bulus formül (I) ya da (Ia)'nin antiviral madde olarak kullanilan nükleozid analoglari ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11379798P | 1998-12-23 | 1998-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102501T2 true TR200102501T2 (tr) | 2002-01-21 |
Family
ID=22351590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02501T TR200102501T2 (tr) | 1998-12-23 | 1999-12-22 | Antiviral nükleozid analoglar. |
Country Status (27)
Country | Link |
---|---|
US (3) | US6358963B1 (tr) |
EP (1) | EP1140937B1 (tr) |
JP (1) | JP2002533470A (tr) |
KR (1) | KR100653485B1 (tr) |
CN (1) | CN1117751C (tr) |
AP (1) | AP2001002207A0 (tr) |
AT (1) | ATE254126T1 (tr) |
AU (1) | AU760875B2 (tr) |
BR (1) | BR9916849A (tr) |
CA (1) | CA2355712C (tr) |
CZ (1) | CZ20012352A3 (tr) |
DE (1) | DE69912842T2 (tr) |
DK (1) | DK1140937T3 (tr) |
EA (1) | EA004767B1 (tr) |
ES (1) | ES2209532T3 (tr) |
HU (1) | HUP0104827A3 (tr) |
ID (1) | ID30477A (tr) |
IL (1) | IL143867A0 (tr) |
MX (1) | MXPA01006425A (tr) |
NO (1) | NO20013163L (tr) |
NZ (1) | NZ513094A (tr) |
OA (1) | OA11741A (tr) |
PT (1) | PT1140937E (tr) |
TR (1) | TR200102501T2 (tr) |
UY (1) | UY25878A1 (tr) |
WO (1) | WO2000039143A2 (tr) |
ZA (1) | ZA200105702B (tr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE254126T1 (de) * | 1998-12-23 | 2003-11-15 | Shire Biochem Inc | Antivirale nukleosidanaloga |
ATE360016T1 (de) | 2000-02-11 | 2007-05-15 | Shire Biochem Inc | Ein stereoselektives verfahren zur herstellung von nukleosidanalogen |
AU2003261114A1 (en) * | 2002-07-03 | 2004-02-09 | Triangle Pharmaceuticals, Inc. | Combination therapy with 1,3-dioxolanes and inosine monophosphate dehydrogenase inhibitors |
US6855821B2 (en) | 2002-08-06 | 2005-02-15 | Pharmasset, Ltd. | Processes for preparing 1,3-dioxolane nucleosides |
US7706405B2 (en) * | 2002-09-12 | 2010-04-27 | Interdigital Technology Corporation | System for efficient recovery of Node-B buffered data following MAC layer reset |
EP1573019B1 (en) | 2002-11-18 | 2009-01-14 | Shire BioChem Inc. | Stereoselective process for the production of dioxolane nucleoside analogues |
DE10335061B4 (de) * | 2003-07-31 | 2005-11-17 | Wacker-Chemie Gmbh | Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten |
EP1720840B1 (en) | 2004-02-03 | 2016-02-03 | Emory University | Methods to manufacture 1,3-dioxolane nucleosides |
US7322412B2 (en) * | 2004-08-30 | 2008-01-29 | Halliburton Energy Services, Inc. | Casing shoes and methods of reverse-circulation cementing of casing |
ATE516249T1 (de) * | 2008-03-20 | 2011-07-15 | Befesa Salzschlacke Gmbh | Hochtonerdehaltiger rohstoff und verfahren zur herstellung |
EP2606895A4 (en) * | 2010-10-12 | 2014-04-02 | Univ Wuhan | TRANSDERMAL ABSORPTION STAMP OF ANTIVIRAL DRUG AND METHOD FOR PREPARING THE SAME |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000137A (en) | 1975-06-10 | 1976-12-28 | American Home Products Corporation | Antitumor derivatives of periodate-oxidized nucleosides |
US4041037A (en) | 1975-06-10 | 1977-08-09 | American Home Products Corporation | Antitumor derivatives of periodate-oxidized cytidine |
JPS5668674A (en) | 1979-11-08 | 1981-06-09 | Shionogi & Co Ltd | 5-fluorouracil derivative |
JPS5738774A (en) | 1980-08-19 | 1982-03-03 | Chugai Pharmaceut Co Ltd | Uracil derivative and its preparation |
US4479942A (en) | 1981-08-10 | 1984-10-30 | Fujisawa Pharmaceutical Co., Ltd. | Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof |
IL86007A0 (en) * | 1987-04-09 | 1988-09-30 | Wellcome Found | 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them |
HU198933B (en) | 1987-11-02 | 1989-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new xanthine derivatives and pharmaceutical compositions comprising same as active ingredient |
US5041449A (en) | 1988-04-11 | 1991-08-20 | Iaf Biochem International, Inc. | 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections |
US5047407A (en) | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
US5270315A (en) | 1988-04-11 | 1993-12-14 | Biochem Pharma Inc. | 4-(purinyl bases)-substituted-1,3-dioxlanes |
NZ228645A (en) * | 1988-04-11 | 1991-09-25 | Iaf Biochem Int | 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections |
US4987224A (en) | 1988-08-02 | 1991-01-22 | University Of Georgia Research Foundation, Inc. | Method of preparation of 2',3'-dideoxynucleosides |
WO1994014802A1 (en) | 1989-02-08 | 1994-07-07 | Biochem Pharma Inc. | Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
PT95516A (pt) * | 1989-10-06 | 1991-08-14 | Wellcome Found | Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos |
US5914331A (en) | 1990-02-01 | 1999-06-22 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US5276151A (en) | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US5700937A (en) | 1990-02-01 | 1997-12-23 | Emory University | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds |
US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
JP2960164B2 (ja) | 1990-11-13 | 1999-10-06 | バイオケム ファーマ インコーポレイテッド | 抗ウイルス特性を有する置換1,3−オキサチオラン類および置換1,3−ジチオラン類 |
AU9125991A (en) | 1990-12-05 | 1992-07-08 | University Of Georgia Research Foundation, Inc., The | Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides |
US5179104A (en) | 1990-12-05 | 1993-01-12 | University Of Georgia Research Foundation, Inc. | Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides |
US5925643A (en) | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
US5444063A (en) | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
NZ241625A (en) | 1991-02-22 | 1996-03-26 | Univ Emory | 1,3-oxathiolane derivatives, anti-viral compositions containing such and method of resolving racemic mixture of enantiomers |
WO1992018517A1 (en) | 1991-04-17 | 1992-10-29 | Yale University | Method of treating or preventing hepatitis b virus |
GB9109506D0 (en) | 1991-05-02 | 1991-06-26 | Wellcome Found | Therapeutic nucleosides |
GB9110874D0 (en) | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
ZA923641B (en) | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
GB9200150D0 (en) * | 1992-01-06 | 1992-02-26 | Wellcome Found | Therapeutic nucleosides |
US5869461A (en) | 1995-03-16 | 1999-02-09 | Yale University | Reducing toxicity of L-nucleosides with D-nucleosides |
GB9525606D0 (en) * | 1995-12-14 | 1996-02-14 | Iaf Biochem Int | Method and compositions for the synthesis of dioxolane nucleosides with - configuration |
US5792773A (en) | 1996-11-15 | 1998-08-11 | Yale University | L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection |
ATE254126T1 (de) * | 1998-12-23 | 2003-11-15 | Shire Biochem Inc | Antivirale nukleosidanaloga |
-
1999
- 1999-12-22 AT AT99960757T patent/ATE254126T1/de not_active IP Right Cessation
- 1999-12-22 CN CN99816209A patent/CN1117751C/zh not_active Expired - Fee Related
- 1999-12-22 PT PT99960757T patent/PT1140937E/pt unknown
- 1999-12-22 NZ NZ513094A patent/NZ513094A/en unknown
- 1999-12-22 AP APAP/P/2001/002207A patent/AP2001002207A0/en unknown
- 1999-12-22 JP JP2000591054A patent/JP2002533470A/ja active Pending
- 1999-12-22 EA EA200100711A patent/EA004767B1/ru not_active IP Right Cessation
- 1999-12-22 DE DE69912842T patent/DE69912842T2/de not_active Expired - Lifetime
- 1999-12-22 KR KR1020017008068A patent/KR100653485B1/ko not_active IP Right Cessation
- 1999-12-22 ES ES99960757T patent/ES2209532T3/es not_active Expired - Lifetime
- 1999-12-22 CZ CZ20012352A patent/CZ20012352A3/cs unknown
- 1999-12-22 TR TR2001/02501T patent/TR200102501T2/tr unknown
- 1999-12-22 CA CA002355712A patent/CA2355712C/en not_active Expired - Fee Related
- 1999-12-22 US US09/468,813 patent/US6358963B1/en not_active Expired - Fee Related
- 1999-12-22 WO PCT/CA1999/001229 patent/WO2000039143A2/en active IP Right Grant
- 1999-12-22 DK DK99960757T patent/DK1140937T3/da active
- 1999-12-22 EP EP99960757A patent/EP1140937B1/en not_active Expired - Lifetime
- 1999-12-22 BR BR9916849-9A patent/BR9916849A/pt not_active IP Right Cessation
- 1999-12-22 IL IL14386799A patent/IL143867A0/xx unknown
- 1999-12-22 OA OA1200100171A patent/OA11741A/en unknown
- 1999-12-22 MX MXPA01006425A patent/MXPA01006425A/es not_active Application Discontinuation
- 1999-12-22 AU AU17657/00A patent/AU760875B2/en not_active Ceased
- 1999-12-22 HU HU0104827A patent/HUP0104827A3/hu unknown
- 1999-12-22 ID IDW00200101622A patent/ID30477A/id unknown
- 1999-12-23 UY UY25878A patent/UY25878A1/es unknown
-
2001
- 2001-06-22 NO NO20013163A patent/NO20013163L/no not_active Application Discontinuation
- 2001-06-29 US US09/893,605 patent/US6545001B2/en not_active Expired - Fee Related
- 2001-07-11 ZA ZA200105702A patent/ZA200105702B/en unknown
-
2003
- 2003-02-28 US US10/375,121 patent/US20040058893A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO961377L (no) | Distamycin A-analoger som antitumor eller antivirale midler | |
DK1280813T3 (da) | Antivirale pyrimidin-nukleosidanaloger | |
CY1116145T1 (el) | S-φθορομεθυλεστερας 6.αλφα.,9.αλφα-διφθορο-17.αλφα.-'(2-φουρανυλκαρβοξυλ) οξυ]-11.βητα.-υδροξυ-16.αλφα.-μεθυλ-3-οξο-ανδροστ-1,4-διεν-17-καρβοθειοτικου οξεος ως αντιφλεγμονωδης παραγοντας | |
TR200201001T2 (tr) | Pürin türevleri | |
BR0111639A (pt) | Uso de uma molécula de ácido oligodeoxinucléico, e composição farmacêutica contendo a mesma | |
NO20035524D0 (no) | 4'-substituerte nukleosider | |
DZ3007A1 (fr) | Analogues de (1 R, CIS)-4-(6-amino-9H-purin-9-YL)-2-cyclopentène-1-methanol comme agents antiviraux. | |
BG106569A (en) | Purine derivatives | |
HUP0001843A2 (hu) | Eljárás nukleozid analógok szintézisére | |
MY122262A (en) | Lh-rh peptide analogues their uses and pharmaceutical compositions containing them | |
EA199900937A1 (ru) | Фармацевтические композиции, содержащие вориконазол | |
TR199800436A2 (tr) | Primidin türevlerinin kanserin önlenmesi için kullanilmasi. | |
PT996430E (pt) | Composicoes de analogos nucleotidicos | |
MA27501A1 (fr) | Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3 | |
TR200102501T2 (tr) | Antiviral nükleozid analoglar. | |
DE60031886D1 (de) | Purinderivate | |
MXPA02012493A (es) | 1-aril-4-oxo, 1,4-dihidro-3-quinolincarboxamidas como agentes antivirales. | |
SE9801494D0 (sv) | Novel use | |
DK1250337T3 (da) | Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter | |
BR0115139A (pt) | Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante | |
TR200200494T2 (tr) | Yağlı asit sintazı inhibitörleri. | |
SE9604582D0 (sv) | Novel compounds | |
BR9907426A (pt) | Tetrahidronaftalenos | |
BR0210201A (pt) | Composição | |
SE9603726D0 (sv) | Novel compounds |